Mean scores with corresponding standard deviation of BREAST‐Q domains in different populations. Scale 0–100; higher scores represent higher quality/function. Normative (Mundy et al. [46]): study performed 2017 in the U.S., general population sample (n = 1,200), mean age 54 ± 13 years. Zhong et al. [47]: study performed 2009–2010 in Canada; n = 106 (delayed implant reconstruction, n = 76; immediate implant reconstruction, n = 30); age distribution, ≤49 years (68%), 50–59 years (28%), and ≥60 years (13%); median time since surgery, preoperative and 12 months postoperative. Rosson et al. [48]: study performed 2008–2009 in the U.S., n = 170 preoperative patients (scheduled for immediate reconstruction, n = 117; delayed, n = 21; revision surgery, n = 32), mean age 50.3 ± 9.5 years. O'Connell et al. [43]: study performed 2010–2016 in the United Kingdom, patients with breast‐conserving therapy only (n = 200), mean age 60.0 ± 11.1 years, time since surgery 35.5 ± 17.8 months. Barone et al. [49]: study performed 2005–2016 in Italy, n = 144 (unilateral REC‐I, n = 121; bilateral REC‐I, n = 23), mean age 54 years, median time since surgery 16 months. Hwang et al. [50]: study performed 2016 in the U.S., survey (n = 3,977) of patients with CPM (n = 1,598; CPM no REC, n = 328 vs. CPM with REC, n = 1,270) vs. no CPM (n = 2,379), mean age 57 ± 9.7 years, median time since surgery 4.6 ± 6.5 years. Koslow et al. [51]: study performed 2000–2007 (CPM) and 2008–2010 (no CPM) in the U.S., n = 294 (CPM with REC‐I, n = 112 vs. no CPM, n = 182), mean age CPM 46.6 years (range 33–75 years) vs. no CPM 50.2 years (23–76 years), mean time since surgery CPM 51.9 months vs. no CPM 52.7 months. Ng et al. [52]: study performed 2000–2010 in Australia, n = 143 (mastectomy, n = 79 vs. reconstruction, n = 69), mean age 54.5 ± 12.9 years, median time since surgery unknown.